Srinivasan & Joseph (2026)
- Authors: Mythily Srinivasan, Paule Valery Joseph
- Institutes: Indiana University, Purdue University Indianapolis, Indianapolis, United States, National Institutes of Health, Bethesda, United States
- Publisher: Frontiers in Medicine
- Link: DOI
Summary
This paper introduces a novel biological link between taste dysfunction and the debilitating fatigue seen in ME/CFS and Long-COVID. By identifying a specific signaling pathway involving ATP, it offers a potential new way to measure disease severity and provides a target for future diagnostic tools and treatments. The proposal of taste testing as a non-invasive screening tool could significantly simplify the clinical evaluation of patients with post-viral illnesses.
What was researched?
This perspective article explores the hypothesis that defects in ATP signaling through specific receptors, namely P2X2 and P2X3, cause both taste dysfunction (dysgeusia) and the core symptoms of ME/CFS.
Why was it researched?
The research aimed to identify objective biomarkers for ME/CFS by leveraging the clinical and pathological similarities between post-viral Long-COVID symptoms and traditional ME/CFS presentations.
How was it researched?
The authors synthesized existing literature on cellular metabolism, inflammation, and autonomic dysregulation while utilizing data from NIH-RECOVER shared resources to support their hypothesis.
What has been found?
The authors propose that impaired ATP release from Type II taste receptor cells mirrors systemic energy deficits that drive post-exertional malaise. They found that chemosensory dysfunction may serve as a potential indicator of the progression and severity of post-exertional malaise.
Discussion
While acknowledging that taste issues can be complicated by external factors like nutrient deficiencies or medication side effects, the authors argue the underlying purinergic signaling mechanism remains a strong candidate for investigation.
Conclusion & Future Work
The study concludes that taste dysfunction is a significant but overlooked clinical feature of ME/CFS. Future research should prioritize investigating the role of purinergic receptors in the development of post-viral chronic illnesses.